Special Reports

Editor's Recommendations
Most Read Articles
Rachel Soon, 4 days ago

With an estimated 1.3 million Malaysians still living with uncorrected cataracts, pharmacists are stepping up for training to help identify and refer those individuals to treatment.

05 Aug 2018
In the treatment of proliferative diabetic retinopathy (DR), eyes gain vision and rarely develop vision-impairing central-involved diabetic macula oedema (DME) over 2 years with ranibizumab, according to a posthoc analysis. In contrast, factors such as poor glycaemic control and more severe DR increase the likelihood of losing visual acuity and developing DME following panretinal photocoagulation (PRP).